Design, synthesis and biological evaluation of novel isoalantolactone-benzylamine derivatives leading to the discovery of a PARP1 inhibitor with selective cytotoxicity against MCF-7 breast cancer cells
Fields of Study & Subjects
PARP inhibition in cancer therapy
Phytochemicals and Medicinal Plants
Bioactive Compounds and Antitumor Agents
Publication details
- Journal / source
- Bioorganic Chemistry
- Publisher
- Elsevier BV
- Volume
- 170
- Pages
- 109521–109521
- Publication date
- 20 January 2026
- Language
- EN